Structural magnetic resonance (MR) and vesicular acetylcholine transporter (VAChT) [18F]-fluoroethoxybenzovesamicol ([18F]-FEOBV) PET imaging was obtained in a sample of 16 PSP subjects. Here, SLC18A3 is linked to supranuclear palsy, progressive, 1.